Related Experiment Video
Updated: Jan 1, 2026
Safety Precautions and Operating Procedures in an ABSL-4 Laboratory: 3. Aerobiology
Published on: October 3, 2016
Accelerating Action in Global Health Security: Global Biosecurity Dialogue as a Model for Advancing the Global Health
Sabrina Brizee1, Katherine Budeski1, Wilmot James1
1Sabrina Brizee, MSc, is a consultant, Global Biological Policy and Programs, NTI, Washington, DC, and International Project Officer, National Institute for Public Health and the Environment, Bilthoven, The Netherlands. Katherine Budeski is a Program Assistant; Wilmot James, PhD, is a consultant; Michelle Nalabandian, MFS, is Program Officer; Hayley Anne Severance, MPH, is Senior Program Officer; and Elizabeth E. Cameron, PhD, is Vice President; all in Global Biological and Policy Programs, NTI, Washington, DC. Dr. James is also a Visiting Professor of Political Science and Pediatrics, Columbia University, New York, NY. Diederik A. Bleijs,, PhD, is Head of the Biosecurity Office, and Mark W. J. van Passel, PhD, is Project Leader; both in the National Institute for Public Health and the Environment, Bilthoven, The Netherlands. Scott J. Becker, MS, is Executive Director, Association of Public Health Laboratories, Silver Spring, MD. Sacha Wallace-Sankarsingh, MSc, is Biorisk Manager, Laboratory Services and Networks, Caribbean Public Health Agency, Port of Spain, Trinidad and Tobago. Anthony Ahumibe, MPH, is Senior Laboratory Technical Advisor; Emmanuel Agogo, MBBS, is Deputy Director General; and Chikwe Ihekweazu, MBBS, is Director General; all at the Nigeria Centre for Disease Control, Abuja, Nigeria. Simo Nikkari, MD, PhD, is Professor, Centre for Biothreat Preparedness, Helsinki, Finland. Maureen Ellis, MS, is Executive Director, International Federation of Biosafety Associations, Ottawa, Ontario, Canada. Ernesto Gozzer, MD, is Associate Professor, Universidad Peruana Cayetano Heredia, Lima, Peru. Immaculate Sware Semesi, PhD, is a Member of Parliament, Parliament of the United Republic of Tanzania, Dodoma, Tanzania. Zibusiso M. Masuku is Biosafety Technical Manager, and Chair of the Institutional Biosafety and Biosecurity Committee, National Institute for Communicable Diseases, Johannesburg, South Africa. Dr. Aamer Ikram is Executive Director, National Institute of Health, Islamabad, Pakistan. Faheem Tahir, PhD, is Chief, Public Health Laboratories Division, National Institute of Health, Islamabad, Pakistan. Irma Makalinao, MD, is Professor and Special Assistant to the Dean, College of Medicine, University of the Philippines, Manila, Philippines.
Abstract:
Biosecurity and biosafety measures are designed to mitigate intentional and accidental biological risks that pose potentially catastrophic consequences to a country's health system, security, and political and economic stability. Unfortunately, biosecurity and biosafety are often under-prioritized nationally, regionally, and globally. Security leaders often deemphasize accidental and deliberate biological threats relative to other challenges to peace and security. Given emerging biological risks, including those associated with rapid technological advances and terrorist and state interest in weapons of mass destruction, biosecurity deserves stronger emphasis in health and security fora. The Global Biosecurity Dialogue (GBD) was initiated to align national and regional donor initiatives toward a common set of measurable targets. The GBD was launched by the Nuclear Threat Initiative (NTI), with support from Global Affairs Canada's Weapons Threat Reduction Program and the Open Philanthropy Project, and in coordination with the government of The Netherlands as the 2018-19 Chair of the Global Health Security Agenda (GHSA) Action Package Prevent-3 (APP3) on Biosafety and Biosecurity. The GBD provides a multisectoral forum for sharing models, enabling new actions to achieve biosecurity-related targets, and promoting biosecurity as an integral component of health security. The GBD has contributed to new national and continent-wide actions, including the African Union and Africa Centres for Disease Control and Prevention's new regional Initiative to Strengthen Biosafety and Biosecurity in Africa. Here we present the GBD as a model for catalyzing action within APP3. We describe how the benefits of this approach could expand to other GHSA Action Packages and international health security initiatives.
More Related Videos
09:54Safety Precautions and Operating Procedures in an ABSL-4 Laboratory: 1. Biosafety Level 4 Suit Laboratory Suite Entry and Exit Procedures
Published on: October 3, 2016
10:11Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
Published on: September 27, 2014
Related Concept Videos
01:28International Nursing Organizations II
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
01:18Steps in Outbreak Investigation
01:26Principles of Disease Surveillance
01:26Methods Of Healthcare Delivery System
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
01:30Primary Healthcare Services
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
01:25Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...